NLRP3 and diabetic kidney disease: NLRP3 inflammasomes and NF-κB are core regulatory molecules in the inflammatory response of DKD: its activation releases the pro-inflammatory cytokines IL-1β/IL-18, while the latter promotes the production of pro-inflammatory cytokines such as TNF-α/IL-6.